Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
International Reviews of Immunology|December 16, 2006
Overview of tumor cell-based vaccinesJohn Copier, Angus DalgleishCurrent Opinion in Molecular Therapeutics|February 9, 2010
Whole-cell vaccines: A failure or a success waiting to happen?John Copier, Angus DalgleishMolecular Diagnosis & Therapy|December 13, 2006
Biomarkers for the development of cancer vaccines: current statusJohn Copier, Mike Whelan, Angus DalgleishCurrent Opinion in Drug Discovery & Development|February 20, 2008
Technical challenges facing therapeutic cancer vaccinesStephen Ward, John Copier, Angus DalgleishVaccine|November 2, 2007
Cell based cancer vaccines: regulatory and commercial developmentJohn Copier, Stephen Ward, Angus DalgleishImmunotherapy|April 6, 2011
Current status and future applications of cellular therapies for cancerJohn Copier, Mark Bodman-Smith, Angus DalgleishScientific Reports|February 9, 2019
In vitro culture with gemcitabine augments death receptor and NKG2D ligand expression on tumour cellsAndrew M Gravett, Angus G Dalgleish, John CopierImmunology and Cell Biology|June 26, 2013
Tripartite immune cell co-operation in the Bacillus Calmette Guérin-induced activation of γδ T cellsDaniel W Fowler, John Copier, Angus G Dalgleish, et al.Cancer Immunology, Immunotherapy : CII|May 15, 2017
Zoledronic acid renders human M1 and M2 macrophages susceptible to Vδ2+ γδ T cell cytotoxicity in a perforin-dependent mannerDaniel W Fowler, John Copier, Angus G Dalgleish, et al.Intervirology|July 19, 2005
Gene expression changes induced by a recombinant E1-/E3- adenovirus type 5 vector in human mammary epithelial cellsAngelo G Scibetta, John Copier, Angela Barrett, et al.Pageof 2